Works by Koenig, Franz

Results: 46
    1
    2

    Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.

    Published in:
    Statistics in Biopharmaceutical Research, 2020, v. 12, n. 4, p. 483, doi. 10.1080/19466315.2020.1790415
    By:
    • Stallard, Nigel;
    • Hampson, Lisa;
    • Benda, Norbert;
    • Brannath, Werner;
    • Burnett, Thomas;
    • Friede, Tim;
    • Kimani, Peter K.;
    • Koenig, Franz;
    • Krisam, Johannes;
    • Mozgunov, Pavel;
    • Posch, Martin;
    • Wason, James;
    • Wassmer, Gernot;
    • Whitehead, John;
    • Williamson, S. Faye;
    • Zohar, Sarah;
    • Jaki, Thomas
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis.

    Published in:
    Wiener Klinische Wochenschrift, 2022, v. 134, n. 23/24, p. 883, doi. 10.1007/s00508-022-02098-9
    By:
    • Karolyi, Mario;
    • Kaltenegger, Lukas;
    • Pawelka, Erich;
    • Kuran, Avelino;
    • Platzer, Moritz;
    • Totschnig, David;
    • Koenig, Franz;
    • Hoepler, Wolfgang;
    • Laferl, Hermann;
    • Omid, Sara;
    • Seitz, Tamara;
    • Traugott, Marianna;
    • Arthofer, Sigrun;
    • Erlbeck, Lea;
    • Jaeger, Stefan;
    • Kettenbach, Alina;
    • Assinger, Alice;
    • Wenisch, Christoph;
    • Zoufaly, Alexander
    Publication type:
    Article
    15
    16
    17

    Commentary on Parker and Weir.

    Published in:
    Clinical Trials, 2020, v. 17, n. 5, p. 567, doi. 10.1177/1740774520941420
    By:
    • Bretz, Frank;
    • Koenig, Franz
    Publication type:
    Article
    18

    Endpoints for randomized controlled clinical trials for COVID-19 treatments.

    Published in:
    Clinical Trials, 2020, v. 17, n. 5, p. 472, doi. 10.1177/1740774520939938
    By:
    • Dodd, Lori E;
    • Follmann, Dean;
    • Wang, Jing;
    • Koenig, Franz;
    • Korn, Lisa L;
    • Schoergenhofer, Christian;
    • Proschan, Michael;
    • Hunsberger, Sally;
    • Bonnett, Tyler;
    • Makowski, Mat;
    • Belhadi, Drifa;
    • Wang, Yeming;
    • Cao, Bin;
    • Mentre, France;
    • Jaki, Thomas
    Publication type:
    Article
    19
    20

    Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593‐606, Sep/Oct 2018., DOI:https://doi.org/10.1002/pst.1873

    Published in:
    Pharmaceutical Statistics, 2019, v. 18, n. 3, p. 284, doi. 10.1002/pst.1942
    By:
    • Jaki, Thomas;
    • Gordon, Allan;
    • Forster, Pamela;
    • Bijnens, Luc;
    • Bornkamp, Bjoern;
    • Brannath, Werner;
    • Fontana, Roberto;
    • Gasparini, Mauro;
    • Hampson, Lisa V.;
    • Jacobs, Tom;
    • Jones, Byron;
    • Paoletti, Xavier;
    • Posch, Martin;
    • Titman, Andrew;
    • Vonk, Richardus;
    • Koenig, Franz
    Publication type:
    Article
    21
    22
    23

    Geriatric polytrauma.

    Published in:
    Wiener Klinische Wochenschrift, 2005, v. 117, n. 4, p. 145, doi. 10.1007/s00508-004-0290-y
    By:
    • Aldrian, Silke;
    • Nau, Thomas;
    • Koenig, Franz;
    • Vécsei, Vilmos
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Selection and bias-Two hostile brothers.

    Published in:
    Statistics in Medicine, 2010, v. 29, n. 1, p. 1, doi. 10.1002/sim.3716
    By:
    • Bauer, Peter;
    • Koenig, Franz;
    • Brannath, Werner;
    • Posch, Martin
    Publication type:
    Article
    31
    32
    33
    34
    35

    Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 9, p. 948, doi. 10.1111/apt.17456
    By:
    • Pericàs, Juan M.;
    • Di Prospero, Nicholas A.;
    • Anstee, Quentin M.;
    • Mesenbrinck, Peter;
    • Kjær, Mette S.;
    • Rivera‐Esteban, Jesús;
    • Koenig, Franz;
    • Sena, Elena;
    • Pais, Raluca;
    • Manzano, Ramiro;
    • Genescà, Joan;
    • Tacke, Frank;
    • Ratziu, Vlad;
    • DiProspero, Nicholas A.;
    • Kara, Leila;
    • Meyer, Elias;
    • Duca, Anna;
    • Kline, Timothy;
    • Aaes‐Jørgensen, Anders;
    • Balthaus, Tania
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

    Published in:
    2020
    By:
    • Dimairo, Munyaradzi;
    • Pallmann, Philip;
    • Wason, James;
    • Todd, Susan;
    • Jaki, Thomas;
    • Julious, Steven A.;
    • Mander, Adrian P.;
    • Weir, Christopher J.;
    • Koenig, Franz;
    • Walton, Marc K.;
    • Nicholl, Jon P.;
    • Coates, Elizabeth;
    • Biggs, Katie;
    • Hamasaki, Toshimitsu;
    • Proschan, Michael A.;
    • Scott, John A.;
    • Ando, Yuki;
    • Hind, Daniel;
    • Altman, Douglas G.;
    • on behalf of the ACE Consensus Group
    Publication type:
    journal article